nach oben

Erschienen in:

02.11.2017 | Original Article

Prognostic Prediction of Oral Squamous Cell Carcinoma by E-Cadherin and N-Cadherin Expression in Overall Cells in Tumor Nests or Tumor Cells at the Invasive Front

verfasst von: Yuu Ozaki-Honda, Sachiko Seki, Mutsunori Fujiwara, Masaaki Matsuura, Shuichi Fujita, Hisazumi Ikeda, Masahiro Umeda, Takao Ayuse, Tohru Ikeda

Erschienen in: Cancer Microenvironment | Ausgabe 1-3/2017

Einloggen, um Zugang zu erhalten

Abstract

Epithelial-mesenchymal transition (EMT) is a significant process in the invasion and metastasis of cancers including oral squamous cell carcinoma (OSCC), and the cadherin switch has been identified as one of the hallmarks of EMT. The aim of the present study was to evaluate the significance of the cadherin switch in the prognosis of OSCC and generate a model for prognostic predictions. Seventy-six biopsy and/or initial surgical specimens from OSCC patients were immunohistochemically analyzed for the expression of E-cadherin and N-cadherin in either overall OSCC cells in tumor nests or in OSCC cells at the invasive front. Among 76 OSCC cases, overall OSCC cells in tumor nests were negative for the expression of E-cadherin in 10 cases and positive for that of N-cadherin in 53 cases. Among 10 cases negative for the expression of E-cadherin, 4 cases were positive for that of N-cadherin. In OSCC cells at the invasive front, the expression of E-cadherin was negative in 62 cases, while that of N-cadherin was positive in 39 cases. Among 62 cases negative for the expression of E-cadherin, 33 cases were positive for that of N-cadherin. A logistic regression analysis showed that a model using the evaluation of N-cadherin expression in overall OSCC cells in tumor nests with a cut-off point of 70 years old was the best fit model. These results suggest that N-cadherin has significant value in prognostic predictions for OSCC patients.

Neville BW, Damm DD, Allen CM, Bouquot JE (eds) (2009) Oral and maxillofacial pathology, 3rd edn. Saunders, St. Louis, pp 409–421

Chang JS, Lo HI, Wong TY, Huang CC, Lee WT, Tsai ST et al (2013) Investigating the association between oral hygiene and head and neck cancer. Oral Oncol 49:1010–1017CrossRefPubMed

Tsai ST, Wong TY, CY O, Fang SY, Chen KC, Hsiao JR et al (2014) The interplay between alcohol consumption, oral hygiene, ALDH2 and ADH1B in the risk of head and neck cancer. Int J Cancer 135:2424–2436CrossRefPubMed

Barness L, Eveson JW, Reichart P, Sidransky D (eds) (2005) Pathology and genetics of head and neck Tumours. World Health Organization classification of Tumours. IARC Press, Lyon, pp 166–175

Gupta B, Johnson NW (2014) Systematic review and meta-analysis of association of smokeless tobacco and of betel quid without tobacco with incidence of oral cancer in South Asia and the Pacific. PLoS One 9:e113385CrossRefPubMedPubMedCentral

Marur S, Forastiere AA (2016) Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment. Mayo Clin Proc 91:386–396CrossRefPubMed

Malik UU, Zarina S, Pennington SR (2016) Oral squamous cell carcinoma: key clinical questions, biomarker discovery, and the role of proteomics. Arch Oral Biol 63:53–65CrossRefPubMed

Vigneswaran N, Williams MD (2014) Epidemiologic trends in head and neck cancer and aids in diagnosis. Oral Maxillofac Surg Clin North Am 26:123–141CrossRefPubMedPubMedCentral

Hunter KD, Parkinson EK, Harrison PR (2005) Profiling early head and neck cancer. Nat Rev Cancer 5:127–135CrossRefPubMed

10.

Scully C, Bagan J (2009) Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications. Oral Dis 15:388–399CrossRefPubMed

11.

Katsuno Y, Lamouille S, Derynck R (2013) TGF-beta signaling and epithelial-mesenchymal transition in cancer progression. Curr Opin Oncol 25:76–84CrossRefPubMed

12.

Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119:1420–1428CrossRefPubMedPubMedCentral

13.

Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674CrossRefPubMed

14.

Peinado H, Olmeda D, Cano A (2007) Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7:415–428CrossRefPubMed

15.

Vincent T, Neve EP, Johnson JR, Kukalev A, Rojo F, Albanell J et al (2009) A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition. Nat Cell Biol 11:943–950CrossRefPubMedPubMedCentral

16.

Moustakas A, Heldin CH (2012) Induction of epithelial-mesenchymal transition by transforming growth factor beta. Semin Cancer Biol 22:446–454CrossRefPubMed

17.

Xu J, Lamouille S, Derynck R (2009) TGF-beta-induced epithelial to mesenchymal transition. Cell Res 19:156–172CrossRefPubMedPubMedCentral

18.

Ikushima H, Miyazono K (2010) TGFbeta signalling: a complex web in cancer progression. Nat Rev Cancer 10:415–424CrossRefPubMed

19.

Smith A, Teknos TN, Pan Q (2013) Epithelial to mesenchymal transition in head and neck squamous cell carcinoma. Oral Oncol 49:287–292CrossRefPubMed

20.

Scanlon CS, Van Tubergen EA, Inglehart RC, D'Silva NJ (2013) Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma. J Dent Res 92:114–121CrossRefPubMed

21.

Krisanaprakornkit S, Iamaroon A (2012) Epithelial-mesenchymal transition in oral squamous cell carcinoma. ISRN Oncol 2012:681469

22.

Luo SL, Xie YG, Li Z, Ma JH, Xu X (2014) E-cadherin expression and prognosis of oral cancer: a meta-analysis. Tumour Biol 35:5533–5537CrossRefPubMed

23.

Ren X, Wang J, Lin X, Wang X (2016) E-cadherin expression and prognosis of head and neck squamous cell carcinoma: evidence from 19 published investigations. Onco Targets Ther 9:2447–2453CrossRefPubMedPubMedCentral

24.

da Silva SD, Morand GB, Alobaid FA, Hier MP, Mlynarek AM, Alaoui-Jamali MA et al (2015) Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma. Clin Exp Metastasis 32:55–63CrossRefPubMed

25.

Fan CC, Wang TY, Cheng YA, Jiang SS, Cheng CW, Lee AY et al (2013) Expression of E-cadherin, twist, and p53 and their prognostic value in patients with oral squamous cell carcinoma. J Cancer Res Clin Oncol 139:1735–1744CrossRefPubMed

26.

Tanaka N, Odajima T, Ogi K, Ikeda T, Satoh M (2003) Expression of E-cadherin, alpha-catenin, and beta-catenin in the process of lymph node metastasis in oral squamous cell carcinoma. Br J Cancer 89:557–563CrossRefPubMedPubMedCentral

27.

Zhao D, Tang XF, Yang K, Liu JY, Ma XR (2012) Over-expression of integrin-linked kinase correlates with aberrant expression of snail, E-cadherin and N-cadherin in oral squamous cell carcinoma: implications in tumor progression and metastasis. Clin Exp Metastasis 29:957–969CrossRefPubMed

28.

Pectasides E, Rampias T, Sasaki C, Perisanidis C, Kouloulias V, Burtness B et al (2014) Markers of epithelial to mesenchymal transition in association with survival in head and neck squamous cell carcinoma (HNSCC). PLoS One 9:e94273CrossRefPubMedPubMedCentral

29.

DID M, Pierantoni GM, Feola A, Esposito F, Laino L, DER A et al (2011) Prognostic significance of N-cadherin expression in oral squamous cell carcinoma. Anticancer Res 31:4211–4218

30.

Nguyen PT, Kudo Y, Yoshida M, Kamata N, Ogawa I, Takata T (2011) N-cadherin expression is involved in malignant behavior of head and neck cancer in relation to epithelial-mesenchymal transition. Histol Histopathol 26:147–156PubMed

31.

Yang TL, CT W, Ko JY, Wang CP, Lou PJ, Chang YL (2011) Significance of tumor satellite variables in reflecting the epithelial-mesenchymal transition of tongue cancer. Oral Oncol 47:720–724CrossRefPubMed

32.

Soares MQ, Mendonca JA, Morais MO, Leles CR, Batista AC, Mendonca EF (2015) E-cadherin, beta-catenin, and alpha2beta1 and alpha3beta1 integrin expression in primary oral squamous cell carcinoma and its regional metastasis. Histol Histopathol 30:1213–1222PubMed

33.

Seki S, Fujiwara M, Matsuura M, Fujita S, Ikeda H, Asahina I et al (2011) Prediction of outcome of patients with oral squamous cell carcinoma using vascular invasion and the strongly positive expression of vascular endothelial growth factors. Oral Oncol 47:588–593CrossRefPubMed

34.

Seki S, Fujiwara M, Matsuura M, Fujita S, Ikeda H, Umeda M et al (2014) Prognostic value of podoplanin expression in oral squamous cell carcinoma--a regression model auxiliary to UICC classification. Pathol Oncol Res 20:521–528CrossRefPubMed

35.

Lindenblatt Rde C, Martinez GL, Silva LE, Faria PS, Camisasca DR, Lourenco Sde Q (2012) Oral squamous cell carcinoma grading systems--analysis of the best survival predictor. J Oral Pathol Med 41:34–39CrossRefPubMed

36.

Akaike H (1973) Information theory and an extension of the maximum likelihood principle. In: Petrov BN, Csaki F (eds) Proceeding of the second international symposium on information theory, Budapest, p 267–281

37.

Ukpo OC, Thorstad WL, Zhang Q, Lewis JS Jr (2012) Lack of association of cadherin expression and histopathologic type, metastasis, or patient outcome in oropharyngeal squamous cell carcinoma: a tissue microarray study. Head Neck Pathol 6:38–47CrossRefPubMed

38.

Hanemann JA, Oliveira DT, Nonogaki S, Nishimoto IN, de Carli ML, Landman G et al (2014) Expression of E-cadherin and beta-catenin in basaloid and conventional squamous cell carcinoma of the oral cavity: are potential prognostic markers? BMC Cancer 14:395CrossRefPubMedPubMedCentral

39.

Balasundaram P, Singh MK, Dinda AK, Thakar A, Yadav R (2014) Study of beta-catenin, E-cadherin and vimentin in oral squamous cell carcinoma with and without lymph node metastases. Diagn Pathol 9:145CrossRefPubMedPubMedCentral

40.

Valastyan S, Weinberg RA (2011) Tumor metastasis: molecular insights and evolving paradigms. Cell 147:275–292CrossRefPubMedPubMedCentral

41.

Giampieri S, Manning C, Hooper S, Jones L, Hill CS, Sahai E (2009) Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nat Cell Biol 11:1287–1296CrossRefPubMedPubMedCentral

42.

Friedl P, Gilmour D (2009) Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol 10:445–457CrossRefPubMed

43.

Hashimoto T, Soeno Y, Maeda G, Taya Y, Aoba T, Nasu M et al (2012) Progression of oral squamous cell carcinoma accompanied with reduced E-cadherin expression but not cadherin switch. PLoS One 7:e47899CrossRefPubMedPubMedCentral

44.

Costa LC, Leite CF, Cardoso SV, Loyola AM, Faria PR, Souza PE et al (2015) Expression of epithelial-mesenchymal transition markers at the invasive front of oral squamous cell carcinoma. J Appl Oral Sci 23:169–178CrossRefPubMedPubMedCentral

45.

Angadi PV, Patil PV, Angadi V, Mane D, Shekar S, Hallikerimath S et al (2016) Immunoexpression of epithelial mesenchymal transition proteins E-cadherin, beta-catenin, and N-cadherin in oral squamous cell carcinoma. Int J Surg Pathol 24:696–703CrossRefPubMed

Titel: Prognostic Prediction of Oral Squamous Cell Carcinoma by E-Cadherin and N-Cadherin Expression in Overall Cells in Tumor Nests or Tumor Cells at the Invasive Front
verfasst von: Yuu Ozaki-Honda
Sachiko Seki
Mutsunori Fujiwara
Masaaki Matsuura
Shuichi Fujita
Hisazumi Ikeda
Masahiro Umeda
Takao Ayuse
Tohru Ikeda
Publikationsdatum: 02.11.2017
Verlag: Springer Netherlands
Erschienen in: Cancer Microenvironment / Ausgabe 1-3/2017
Print ISSN: 1875-2292
Elektronische ISSN: 1875-2284
DOI: https://doi.org/10.1007/s12307-017-0201-1

Neu im Fachgebiet Onkologie

24.04.2024 | DGIM 2024 | Nachrichten

Springer Medizin

Prognostic Prediction of Oral Squamous Cell Carcinoma by E-Cadherin and N-Cadherin Expression in Overall Cells in Tumor Nests or Tumor Cells at the Invasive Front

Abstract

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1-3/2017

Human Metaplastic Breast Carcinoma and Decorin

Participation of Tumor-Associated Myeloid Cells in Progression of Amelanotic Melanoma (RMM Tumor Line) in F344 Rats, with Particular Reference to MHC Class II- and CD163-Expressing Cells

The Impact of Microenvironment on the Synovial Sarcoma Transcriptome

Effects of Vacuolar H+-ATPase Inhibition on Activation of Cathepsin B and Cathepsin L Secreted from MDA-MB231 Breast Cancer Cells

Epithelial Mesenchymal Transition (EMT) in Metastatic Breast Cancer in Omani Women

Expression Profiling of the MAP Kinase Phosphatase Family Reveals a Role for DUSP1 in the Glioblastoma Stem Cell Niche

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie